Account
Insider Insights
25.04.2023
EU aims to revamp European pharmaceutical laws

With country health budgets drained following the pandemic, the European Commission aims to reform E...

Read more
Insider Insights
22.03.2023
More clarity given on the proposed changes to comb...

The German government has released information regarding the 20% discounts to combination products e...

Read more
Insider Insights
14.03.2023
Newly agreed Windsor Framework carries significant...

Windsor Framework replaces the Northern Ireland protocol to address issues and provide significant c...

Read more
Insider Insights
09.03.2023
What has occurred in the past year in the Swedish ...

TLV unveils annual report, offering insights into trends and projects that have dominated the past y...

Read more
Insider Insights
09.03.2023
Government announces new action plan for rare dise...

Hope that new action plan and collaboration with the rare diseases community will progress positive ...

Read more
Insider Insights
09.03.2023
The Financial Stabilisation Act is unlikely to off...

DAK-Gesundheit claim that cost saving measures imposed by the GVK Financial Stabilisation Act are un...

Read more
Insider Insights
09.03.2023
CMS declines to revise coverage for FDA-approved t...

CMS denies coverage of FDA-approved treatments that target amyloid for Alzheimer's disease unless th...

Read more
Insider Insights
09.03.2023
NICE issues conditional recommendation for digital...

NICE conditionally recommends eight digitally enabled therapies to treat depression and anxiety in a...

Read more
Insider Insights
09.03.2023
Fimea launches pilot procedure for the evaluation ...

Fimea program aims to standardise the initiation of assessment which are currently different for out...

Read more
Insider Insights
06.03.2023
The Project Orbis initiative

The Project Orbis initiative is an international partnership between medicines regulators in the UK,...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.